how does ipamorelin compare to other growth hormonereleasing peptides Sermorelin vs Ipamorelin: Differences, Benefits, and Which Is Better? CJC-1295/Ipamorelin Benefits, Side Effects, and

Research has examined its role in: GH secretion stimulation via selective GHS-R1a agonism IGF-1 axis modulation and downstream anabolic signalling research Longitudinal bone growth and bone mineral content investigations Body composition and lean tissue research in pre-clinical models Comparative GHRP selectivity and receptor-binding studies Postoperative gastrointestinal motility research via ghrelin receptor pathways Synergistic GH axis research when combined with GHRH analogues such as CJC-1295 Ipamorelin and Longitudinal Bone Growth Research In adult female rats administered Ipamorelin subcutaneously three times daily for 15 days, a dose-dependent increase in longitudinal bone growth rate was observed rising from 42 m/day in the vehicle group to 52 m/day at the highest dose confirming GH-mediated effects on skeletal tissue in pre-clinical models

No active clinical trials are listed on ClinicalTrials.gov as of February 2026

Biotechnol Prog 22:753762 Huh SH, Do HJ, Lim HY, Kim DK, Choi SJ, Song H, Kim NH, Park JK, Chang WK, Chung HM, Kim JH (2007) Optimization of 25 kDa linear polyethylenimine for efficient gene delivery

Tesamorelin is a stabilized GHRH(144) analog and Ipamorelin is a selective ghrelin / GHS-R1a agonist